Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 167 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

Multiple Sclerosis United States

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

Breast Cancer Russian Federation

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis Phase3 Argentina
Brazil
China
Czechia
France
Germany
Greece
Israel
Italy
Japan
Netherlands
Spain
Switzerland
Turkey
United Kingdom
United States
View All

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

Hidradenitis Suppurativa France

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Neovascular Age-related Macular Degeneration Korea, Republic of

Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria

Uncomplicated Plasmodium Falciparum Malaria Phase3 Burkina Faso
Congo, The Democratic Republic of the
Côte D'Ivoire
Gabon
Ghana
India
Kenya
Mali
Niger
Rwanda
Tanzania
Uganda
View All

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

Graft-versus-Host Disease Korea, Republic of

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase2 France
Germany
Italy
Spain
United States
View All

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Uncomplicated Plasmodium Falciparum Malaria Phase2 Burkina Faso
Côte D'Ivoire
Gabon
Ghana
Kenya
Uganda
View All

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Prostatic Neoplasm Phase2 Brazil
Canada
China
Czechia
France
Germany
Italy
Korea, Republic of
Netherlands
Poland
Singapore
Spain
United States
View All